Rivka Gal
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Otorhinolaryngology top 5%
Papers in
-
- Oral and Maxillofacial Pathology 4
- Oncology 12
- Cancer Diagnosis and Treatment 3
- Co-authors
- Rumelia Koren (33 shared papers)Yuval Zohar (8 shared papers)Uzi Gafter (6 shared papers)Yona Kalechman (5 shared papers)Benjamin Sredni (5 shared papers)Avi Livneh (7 shared papers)Adrian Paz (7 shared papers)Michael John Albeck (3 shared papers)
- Journals
- Pathology & Oncology Research (4 papers)Applied Immunohistochemistry (3 papers)Oncology Reports (3 papers)Otolaryngology (3 papers)Applied immunohistochemistry & molecular morphology (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Rivka Gal
65 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 113
- Nephrology 125
- Otorhinolaryngology 66
- Urology 92
- Toxicology 48
- Oncology 252
Countries citing papers authored by Rivka Gal
This map shows the geographic impact of Rivka Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rivka Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rivka Gal more than expected).
Fields of papers citing papers by Rivka Gal
This network shows the impact of papers produced by Rivka Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rivka Gal. The network helps show where Rivka Gal may publish in the future.
Co-authors
The 25 scholars most cited alongside Rivka Gal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 115 | |
| 2 | 2001 | 82 | |
| 3 | 2003 | 75 | |
| 4 | 2004 | 70 | |
| 5 | 1996 | 69 | |
| 6 | 2001 | 58 | |
| 7 | 2003 | 55 | |
| 8 | 1988 | 50 | |
| 9 | 2003 | 47 | |
| 10 | 2002 | 45 | |
| 11 | 1996 | 42 | |
| 12 | 1998 | 39 | |
| 13 | 2001 | 38 | |
| 14 | 2001 | 36 | |
| 15 | Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. | 1999 | 33 |
| 16 | 1992 | 31 | |
| 17 | 2001 | 29 | |
| 18 | 2005 | 25 | |
| 19 | 2005 | 24 | |
| 20 | 2002 | 24 |
About Rivka Gal
Rivka Gal is a scholar working on Oral Surgery, Oncology, Urology, Molecular Biology and Otorhinolaryngology, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers), Hair Growth and Disorders (4 papers), Oral and Maxillofacial Pathology (4 papers), Tracheal and airway disorders (3 papers), Dermatologic Treatments and Research (3 papers), Head and Neck Cancer Studies (3 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Nephrology (125 citations), Otorhinolaryngology (66 citations), Urology (92 citations), Toxicology (48 citations) and Oncology (252 citations). Rivka Gal has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Rumelia Koren, Yuval Zohar, Uzi Gafter, Yona Kalechman, Benjamin Sredni, Avi Livneh, Adrian Paz, Michael John Albeck, Adam Mor and Yoram Dekel. Their work appears in journals such as Pathology & Oncology Research, Applied Immunohistochemistry, Oncology Reports, Otolaryngology and Applied immunohistochemistry & molecular morphology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.